Atomi Financial Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$503K Sell
2,742
-536
-16% -$98.8K 0.02% 712
2025
Q4
$577K Buy
+3,278
New +$536K 0.02% 626
2025
Q3
Sell
-1,800
Closed -$226K 1172
2025
Q2
$226K Buy
+1,800
New +$224K 0.01% 985

Other funds holding BIIB

Atomi Financial Group's BIIB Position: Q1 2026 in Review

Atomi Financial Group reduced its Biogen (BIIB) stake by 16% in Q1 2026, selling an estimated $98.8K and leaving 2,742 shares worth $503K. The position accounts for 0.02% of the portfolio, ranked #712.

Atomi Financial Group first reported a position in BIIB in Q2 2025 and has held it in 3 quarters since. The position peaked at $577K in Q4 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Atomi Financial Group held 2,742 shares of Biogen worth $503K as of Q1 2026.
  • Atomi Financial Group sold 536 Biogen shares in Q1 2026, an estimated $98.8K.
  • Biogen made up 0.02% of Atomi Financial Group's portfolio in Q1 2026, its #712 holding.
  • Atomi Financial Group first reported a position in Biogen in Q2 2025 and has held it in 3 quarters since.
  • Atomi Financial Group's Biogen position peaked at $577K in Q4 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.